A coming of age for personalised medicine?
This article was originally published in Clinica
The recent agreement between UK diagnostics company Enigma Diagnostics and GlaxoSmithKline to commercialise a rapid point-of-care test for different strains of influenza is the latest in a series of deals that underline the growing importance of so-called companion diagnostics. It is now widely expected that this category of diagnostics will have a big influence on healthcare and the future shape of the pharma and diagnostics markets.
You may also be interested in...
Smiths Medical is increasing paraPAC ventilator production from hundreds to thousands a month to fulfill 10,000 units as part of the Ventilator Challenge UK consortium.
UK engineering firm Dyson, best known for its vacuum cleaners, fans and hand driers, plans to make 10,000 specially designed ventilators under a UK government contract.
Production of ventilators is up by tens of thousands of units across Europe, but the supply chain is likely to come under strain with further expansion.